share_log

Molecular Partners AG (OTCMKTS:MLLCF) Sees Significant Decline in Short Interest

Defense World ·  Jan 2, 2023 15:41

Molecular Partners AG (OTCMKTS:MLLCF – Get Rating) was the target of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 113,400 shares, a decrease of 30.0% from the November 30th total of 162,100 shares. Based on an average daily volume of 500 shares, the days-to-cover ratio is presently 226.8 days.

Molecular Partners Stock Up 5.8 %

OTCMKTS MLLCF opened at $6.17 on Monday. Molecular Partners has a 52 week low of $5.16 and a 52 week high of $32.00. The firm's 50-day simple moving average is $6.39 and its two-hundred day simple moving average is $6.19.

Get Molecular Partners alerts:

Molecular Partners Company Profile

(Get Rating)

Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, as well as for diabetic macular edema; and MP0420, a multi-specific DARPin therapeutic candidate for the SARS-CoV-2 virus.

See Also

  • Get a free copy of the StockNews.com research report on Molecular Partners (MLLCF)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Should You Warm up to Generac Stock for the Winter?
  • Is Kintara Therapeutics A Hidden Gem?

Receive News & Ratings for Molecular Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molecular Partners and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment